Denali Therapeutics (DNLI) Enterprise Value (2017 - 2026)
Denali Therapeutics' Enterprise Value was $3.4 billion in Q2 2026, up 198.3% from $1.14 billion a year earlier and up 65.1% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Enterprise Value (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Denali Therapeutics' Enterprise Value was $694.67 million through Jun 30, 2026; for FY2025, it was $1.71 billion, down 18.8% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of -27.6% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $2.11 billion in FY2024 (+8.9%), $1.94 billion in FY2023 (-20.8%), $2.44 billion in FY2022 (-46.7%) and $4.59 billion in FY2021 (-46.8%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q4 2021.
- Compared with a year earlier, Enterprise Value was higher in four of the last eight quarters, with growth averaging 25.3%.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2026 (growth of 198.3%); the worst was Q2 2022 (a decline of 68.9%).
- Per Business Quant data, DNLI's Enterprise Value in the three quarters before Q2 2026 was $2.06 billion (Q1 2026), $1.71 billion (Q4 2025) and $1.28 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Denali Therapeutics | 3.35 Bn | 3.35 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.40 Bn |
| Mar 31, 2026 | 2.06 Bn |
| Dec 31, 2025 | 1.71 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 2.11 Bn |
| Sep 30, 2024 | 3.35 Bn |
| Jun 30, 2024 | 2.43 Bn |
| Mar 31, 2024 | 1.99 Bn |
| Dec 31, 2023 | 1.94 Bn |
| Sep 30, 2023 | 1.74 Bn |
| Jun 30, 2023 | 2.86 Bn |
| Mar 31, 2023 | 1.86 Bn |
| Dec 31, 2022 | 2.44 Bn |
| Sep 30, 2022 | 2.69 Bn |
| Jun 30, 2022 | 2.56 Bn |
| Mar 31, 2022 | 2.99 Bn |
| Dec 31, 2021 | 4.59 Bn |
| Sep 30, 2021 | 5.12 Bn |
API Access
Denali Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();